Showing results (5031-5040 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 28, 2013
Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an "iffy" question!Sónia C Correia, Cristina Carvalho, Susana Cardoso, et al.Current Pharmaceutical Design|May 23, 2012
In vivo imaging of the diseased nervous system: an updateCatherine Sorbara, Thomas Misgeld, Martin KerschensteinerCurrent Pharmaceutical Design|May 23, 2012
Immune therapy of multiple sclerosis--future strategiesSven G Meuth, Kerstin Göbel, Heinz WiendlCurrent Pharmaceutical Design|May 23, 2012
Monoclonal antibodies in the treatment of neuroimmunological diseasesPaulus S Rommer, Robert Patejdl, Uwe K ZettlCurrent Pharmaceutical Design|May 23, 2012
Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administrationMazen Abu-Mugheisib, Reiner Benecke, Uwe K ZettlCurrent Pharmaceutical Design|May 25, 2012
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO familyWenmin Chen, Peng Zhan, Jingde Wu, et al.Current Pharmaceutical Design|May 25, 2012
Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injuryAxelle Caudrillier, Mark R LooneyCurrent Pharmaceutical Design|June 12, 2012
Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosisRobert Schumann, Michael Adamaszek, Norbert Sommer, et al.Current Pharmaceutical Design|June 12, 2012
Epigenetics, depression and antidepressant treatmentAndreas Menke, Torsten Klengel, Elisabeth B BinderCurrent Pharmaceutical Design|August 29, 2014
Predictors of response to TNF antagonistsEva Salgado, Jose Ramon Maneiro, Juan J Gomez-ReinoPageof 1,008